Coverage
-
June 07, 2018
A California federal judge on Thursday combined three separate shareholder suits over an acquisition by Roche Holding AG of cancer drugmaker Ignyta Inc. valued at $1.7 billion, putting the three similar sets of claims over financial disclosures under one judge's purview.
1 other articles on this case.
View all »